tiprankstipranks
Assertio Therapeutics (ASRT)
:ASRT
US Market

Assertio Therapeutics (ASRT) Cash flow

Compare
1,114 Followers

Assertio Therapeutics Cash Flow

ASRT's free cash flow for Q4 2024 was $11.55M. For the 2024 fiscal year, ASRT's free cash flow was decreased by $-22.57M and operating cash flow was $11.55M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ 26.41M$ 49.60M$ 78.60M$ 5.52M$ -65.57M
Investing Cash Flow
$ -48.91M$ 3.10M$ -42.67M$ -18.52M$ 512.80M
Financing Cash Flow
$ -350.00K$ -44.20M$ -7.79M$ 29.03M$ -468.55M
End Cash Position
$ 50.59M$ 73.44M$ 64.94M$ 36.81M$ 20.79M
Free Cash Flow
$ 26.41M$ 48.98M$ 78.32M$ 5.47M$ -65.58M
Currency in USD

Assertio Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis